ATE328888T1 - Radicicol und monocillin und ihre analogen und ihre anwendungen - Google Patents
Radicicol und monocillin und ihre analogen und ihre anwendungenInfo
- Publication number
- ATE328888T1 ATE328888T1 AT01966236T AT01966236T ATE328888T1 AT E328888 T1 ATE328888 T1 AT E328888T1 AT 01966236 T AT01966236 T AT 01966236T AT 01966236 T AT01966236 T AT 01966236T AT E328888 T1 ATE328888 T1 AT E328888T1
- Authority
- AT
- Austria
- Prior art keywords
- monocillin
- radicicol
- analogues
- applications
- sub
- Prior art date
Links
- 229930190086 Monocillin Natural products 0.000 title 1
- XTUZVEOWUSGCSV-HKCOAVLJSA-N Monocillin I Natural products CC1CC2OC2C=C/C=C/C(=O)Cc3cc(O)cc(O)c3C(=O)O1 XTUZVEOWUSGCSV-HKCOAVLJSA-N 0.000 title 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 title 1
- VYGYNVZNSSTDLJ-HKCOAVLJSA-N monorden Natural products CC1CC2OC2C=C/C=C/C(=O)CC3C(C(=CC(=C3Cl)O)O)C(=O)O1 VYGYNVZNSSTDLJ-HKCOAVLJSA-N 0.000 title 1
- WYZWZEOGROVVHK-GTMNPGAYSA-N radicicol Chemical compound C/1=C/C=C/C(=O)CC2=C(Cl)C(O)=CC(O)=C2C(=O)O[C@H](C)C[C@H]2O[C@@H]2\1 WYZWZEOGROVVHK-GTMNPGAYSA-N 0.000 title 1
- 229930192524 radicicol Natural products 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Circuits Of Receivers In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22827700P | 2000-08-25 | 2000-08-25 | |
| US30455301P | 2001-07-11 | 2001-07-11 | |
| US09/938,754 US7115651B2 (en) | 2000-08-25 | 2001-08-24 | Macrocycles and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328888T1 true ATE328888T1 (de) | 2006-06-15 |
Family
ID=27397829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01966236T ATE328888T1 (de) | 2000-08-25 | 2001-08-24 | Radicicol und monocillin und ihre analogen und ihre anwendungen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7115651B2 (de) |
| EP (1) | EP1315732B1 (de) |
| AT (1) | ATE328888T1 (de) |
| AU (1) | AU2001286768A1 (de) |
| DE (1) | DE60120427D1 (de) |
| WO (1) | WO2002016369A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7705120B2 (en) | 2001-06-21 | 2010-04-27 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| US20050182129A1 (en) * | 2002-04-17 | 2005-08-18 | Akiko Ikeda | Hair growth tonic |
| EP1633774B1 (de) | 2003-06-18 | 2010-02-17 | Tranzyme Pharma Inc. | Makrozyklische motilin rezeptorantagonisten |
| JP4575294B2 (ja) | 2003-06-27 | 2010-11-04 | 協和発酵キリン株式会社 | Hsp90ファミリー蛋白質阻害剤 |
| US20070004674A1 (en) * | 2003-08-22 | 2007-01-04 | Kyowa Hakko Kogyo Co. Ltd. | Remedy for diseases associated with immunoglobulin gene translocation |
| US8329683B2 (en) | 2006-06-02 | 2012-12-11 | Nexgenix Pharmaceuticals, Llc | Treatment of neurofibromatosis with radicicol and its derivatives |
| WO2008150302A1 (en) * | 2007-06-04 | 2008-12-11 | Nexgenix Pharmaceuticals | Treatment of neurofibromatosis with radicicol and its derivatives |
| WO2008021213A1 (en) * | 2006-08-11 | 2008-02-21 | Nicolas Winssinger | Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| AU2008287542C1 (en) | 2007-06-01 | 2015-01-22 | The Trustees Of Princeton University | Treatment of viral infections by modulation of host cell metabolic pathways |
| EP2173733A2 (de) * | 2007-06-05 | 2010-04-14 | WINSSINGER, Nicolas | Zusammensetzungen und verfahren mit analogen von radicicol a |
| EP2200653A2 (de) * | 2007-09-10 | 2010-06-30 | University of Massachusetts | Antitumorale mittel gegen mitochondrien |
| US20110190237A1 (en) * | 2008-01-15 | 2011-08-04 | Nexgenix Pharmaceuticals | Macrocyclic Prodrug Compounds Useful as Therapeutics |
| MX2010007755A (es) | 2008-01-15 | 2010-12-21 | Univ Strasbourg | Sintesis de lactonas de acido resorcilico utiles como agentes terapeuticos. |
| US20090258869A1 (en) * | 2008-02-08 | 2009-10-15 | The Regents Of The University Of California | Methods and compounds for treatment or prevention of substance-related disorders |
| EP2254880B8 (de) | 2008-02-21 | 2016-09-21 | OncoSynergy, Inc. | Als Therapeutika geeignete makrocyclische Prodrugverbindungen |
| US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
| WO2016196256A2 (en) | 2015-06-04 | 2016-12-08 | University Of North Carolina At Greensboro | Non-aromatic difluoro analogues of resorcylic acid lactones |
| PT3658148T (pt) | 2017-07-28 | 2024-08-26 | Turning Point Therapeutics Inc | Compostos macrocíclicos e utilizações dos mesmos |
| US20230390416A1 (en) * | 2020-10-16 | 2023-12-07 | The Brigham And Women's Hospital, Inc. | Compositions for inducing tumor immunity and reducing drug tolerance |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR96046E (fr) * | 1966-06-29 | 1972-05-19 | Commercial Solvents Corp | Composé utilisable comme supplément alimentaire pour les animaux. |
| FR96016E (fr) | 1966-06-29 | 1972-05-19 | Commercial Solvents Corp | Composé utilisable comme supplément alimentaire pour les animaux. |
| US3621036A (en) * | 1969-02-27 | 1971-11-16 | Merck & Co Inc | Derivatives of zearalane |
| BE757083A (fr) * | 1970-02-16 | 1971-03-16 | Commercial Solvents Corp | Nouveaux produits a activite antibacterienne |
| BE757082A (fr) * | 1970-02-16 | 1971-03-16 | Commercial Solvents Corp | Procede de preparation de nouveaux produits a activite antibacterienne |
| US3901921A (en) * | 1972-04-25 | 1975-08-26 | Commercial Solvents Corp | Synthesis of zearalanes and related compounds and intermediates useful in the syntheses thereof |
| US4035504A (en) * | 1975-05-12 | 1977-07-12 | Imc Chemical Group, Inc. | Method for treating cholesterolemia by administering resorcylic acid lactone derivatives |
| US4088658A (en) * | 1976-11-04 | 1978-05-09 | Imc Chemical Group, Inc. | Synthesis of dideoxyzearalane and related compounds |
| US4166764A (en) * | 1978-02-01 | 1979-09-04 | W. R. Grace & Co. | Production of monorden |
| US4228079A (en) | 1978-10-30 | 1980-10-14 | W. R. Grace & Co. | Dialkoxy monorden derivatives |
| IE911915A1 (en) | 1990-06-06 | 1991-12-18 | Sankyo Co | Radicicol derivatives, their preparation and their¹anti-tumor activity |
| US5650430A (en) | 1990-06-06 | 1997-07-22 | Sankyo Company, Limited | Radicicol derivatives, their preparation and their anti-tumor activity |
| GB9225396D0 (en) | 1992-12-04 | 1993-01-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5731343A (en) | 1995-02-24 | 1998-03-24 | The Scripps Research Institute | Method of use of radicicol for treatment of immunopathological disorders |
| JP3938936B2 (ja) * | 1995-04-26 | 2007-06-27 | 協和醗酵工業株式会社 | ラディシコール誘導体 |
| JPH09202781A (ja) * | 1996-01-25 | 1997-08-05 | Sankyo Co Ltd | ラディシコール誘導体 |
| ATE266017T1 (de) | 1996-10-25 | 2004-05-15 | Kyowa Hakko Kogyo Kk | Radicicolderivate |
| AU3534499A (en) | 1998-04-24 | 1999-11-16 | Kyowa Hakko Kogyo Co. Ltd. | Radicicol derivatives |
| CA2356622A1 (en) * | 1998-12-24 | 2000-07-06 | Novation Pharmaceuticals Inc. | Compounds which affect mrna stability and uses therefor |
| WO2000061578A1 (en) | 1999-04-09 | 2000-10-19 | Sloan-Kettering Institute For Cancer Research | Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases |
| CA2395136A1 (en) | 1999-12-22 | 2001-06-28 | The Scripps Research Institute | Angiogenesis and vascular permeability modulators and inhibitors |
-
2001
- 2001-08-24 EP EP01966236A patent/EP1315732B1/de not_active Expired - Lifetime
- 2001-08-24 WO PCT/US2001/026577 patent/WO2002016369A2/en not_active Ceased
- 2001-08-24 DE DE60120427T patent/DE60120427D1/de not_active Expired - Lifetime
- 2001-08-24 AU AU2001286768A patent/AU2001286768A1/en not_active Abandoned
- 2001-08-24 AT AT01966236T patent/ATE328888T1/de not_active IP Right Cessation
- 2001-08-24 US US09/938,754 patent/US7115651B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001286768A1 (en) | 2002-03-04 |
| EP1315732B1 (de) | 2006-06-07 |
| WO2002016369A3 (en) | 2002-08-29 |
| EP1315732A2 (de) | 2003-06-04 |
| DE60120427D1 (de) | 2006-07-20 |
| US20020091151A1 (en) | 2002-07-11 |
| US7115651B2 (en) | 2006-10-03 |
| WO2002016369A2 (en) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE328888T1 (de) | Radicicol und monocillin und ihre analogen und ihre anwendungen | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| EP1442016A4 (de) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| CY1108522T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
| SE0302760D0 (sv) | New compounds | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| MXPA04004674A (es) | Ligados de los receptors de los canabinodies. | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| EA199900937A1 (ru) | Фармацевтические композиции, содержащие вориконазол | |
| WO2003053359A3 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
| DE60324544D1 (de) | Muskarin antagonisten | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| BR0105563A (pt) | Derivados e análogos de galantamina | |
| SE9901077D0 (sv) | Novel use | |
| ATE380174T1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
| ATE272617T1 (de) | Sulfonamid-derivate | |
| ATE479657T1 (de) | N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen | |
| CY1108224T1 (el) | Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα | |
| MXPA03010766A (es) | Nuevos compuestos y composiciones como inhibicores de las catepsinas. | |
| SE9801494D0 (sv) | Novel use | |
| ATE308540T1 (de) | Antithrombosemittel | |
| ATE266029T1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| NO20051282L (no) | Antitumorale analoger av lamellariner. | |
| DE60107832D1 (en) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |